Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3251700
Max Phase: Preclinical
Molecular Formula: C16H23N3O6
Molecular Weight: 353.38
Molecule Type: Small molecule
Associated Items:
ID: ALA3251700
Max Phase: Preclinical
Molecular Formula: C16H23N3O6
Molecular Weight: 353.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccc([N+](=O)[O-])cc1)C(=O)O
Standard InChI: InChI=1S/C16H23N3O6/c1-9(2)7-13(16(22)23)18-15(21)14(20)12(17)8-10-3-5-11(6-4-10)19(24)25/h3-6,9,12-14,20H,7-8,17H2,1-2H3,(H,18,21)(H,22,23)/t12-,13+,14+/m1/s1
Standard InChI Key: AXNJBMQISBJVSJ-RDBSUJKOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 353.38 | Molecular Weight (Monoisotopic): 353.1587 | AlogP: 0.44 | #Rotatable Bonds: 9 |
Polar Surface Area: 155.79 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.38 | CX Basic pKa: 8.26 | CX LogP: -1.16 | CX LogD: -1.21 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.37 | Np Likeness Score: -0.08 |
1. Nishizawa R, Saino T, Takita T, Suda H, Aoyagi T.. (1977) Synthesis and structure-activity relationships of bestatin analogues, inhibitors of aminopeptidase B., 20 (4): [PMID:850237] [10.1021/jm00214a010] |
2. Mills B, Isaac RE, Foster R.. (2021) Metalloaminopeptidases of the Protozoan Parasite Plasmodium falciparum as Targets for the Discovery of Novel Antimalarial Drugs., 64 (4.0): [PMID:33534577] [10.1021/acs.jmedchem.0c01721] |
Source(1):